Dexcom DXCM
NASDAQ DXCM
$84.51 +0.63 (+0.75%)
As of: Sep 10, 2026 · 3:59 PM EDT

Dexcom (DXCM) Total Debt Growth (3y) (2013 - 2017)

Analysis

Dexcom (DXCM) Total Debt Growth (3y) (2013 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 24.63%
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn -
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 4.06%
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 4.89%
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 11.72%
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 0.11%
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 252.76%
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn -10.56%
10 Zimmer Biomet Holdings 17.73 Bn 17.32 Bn 1.54 Bn 9.42%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 106.64%
Mar 31, 2016 -39.56%
Dec 31, 2015 -31.00%
Jun 30, 2014 376.22%
Dec 31, 2013 134.85%